Susquehanna International Group, LLP Curis Inc Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023
BUY
$0.51 - $0.78 $6,357 - $9,723
12,466 Added 108.4%
23,966 $14,000
Q4 2022

Feb 14, 2023
SELL
$0.47 - $17.22 $8,677 - $317,915
-18,462 Reduced 61.62%
11,500 $6,000
Q3 2022

Nov 14, 2022
SELL
$0.74 - $15.01 $23,975 - $486,308
-32,399 Reduced 51.95%
29,962 $21,000
Q2 2022

Aug 15, 2022
SELL
$0.71 - $2.43 $69,063 - $236,373
-97,273 Reduced 60.94%
62,361 $61,000
Q1 2022

May 16, 2022
SELL
$2.31 - $5.13 $428,648 - $951,933
-185,562 Reduced 53.76%
159,634 $380,000
Q4 2021

Feb 14, 2022
BUY
$4.45 - $8.09 $20,180 - $36,688
4,535 Added 1.33%
345,196 $1.64 Million
Q3 2021

Nov 15, 2021
SELL
$6.94 - $8.85 $953,750 - $1.22 Million
-137,428 Reduced 28.75%
340,661 $2.67 Million
Q2 2021

Aug 11, 2021
SELL
$7.45 - $16.27 $2.39 Million - $5.23 Million
-321,456 Reduced 40.2%
478,089 $3.86 Million
Q1 2021

May 17, 2021
BUY
$8.78 - $12.8 $6.49 Million - $9.45 Million
738,663 Added 1213.27%
799,545 $9.05 Million
Q4 2020

Feb 16, 2021
BUY
$1.08 - $8.2 $23,506 - $178,472
21,765 Added 55.64%
60,882 $499,000
Q3 2020

Nov 16, 2020
BUY
$0.95 - $1.42 $37,161 - $55,546
39,117 New
39,117 $46,000
Q1 2020

May 15, 2020
SELL
$0.67 - $1.85 $18,544 - $51,204
-27,678 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$1.36 - $2.44 $11,629 - $20,864
8,551 Added 44.71%
27,678 $47,000
Q3 2019

Nov 14, 2019
SELL
$1.74 - $2.83 $11,071 - $18,007
-6,363 Reduced 24.96%
19,127 $43,000
Q2 2019

Aug 16, 2019
BUY
$1.36 - $2.35 $1,090 - $1,884
802 Added 3.25%
25,490 $47,000
Q2 2019

Aug 14, 2019
BUY
$1.36 - $2.35 $3,605 - $6,229
2,651 Added 12.03%
24,688 $46,000
Q1 2019

May 15, 2019
SELL
$0.78 - $2.01 $22,800 - $58,754
-29,231 Reduced 57.02%
22,037 $44,000
Q4 2018

Feb 14, 2019
BUY
$0.62 - $2.25 $31,786 - $115,353
51,268 New
51,268 $35,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email